Belardelli F, Gresser I, Maury C, Duvillard P, Prade M, Maunoury M T
Int J Cancer. 1983 May 15;31(5):649-53. doi: 10.1002/ijc.2910310518.
Administration of highly purified interferon to DBA/2 mice inhibited the growth of interferon-sensitive or interferon-resistant Friend erythroleukemia cells implanted subcutaneously. Injection of interferon at the site of tumor inoculation was more effective than injection of interferon intraperitoneally. Histologic examination of tumors in interferon-treated mice showed extensive areas of tumor-cell necrosis in the absence of an obvious host-cell infiltrate. Interferon inhibited the growth of established subcutaneous tumors and induced complete tumor regression in some mice. Interferon treatment also resulted in an inhibition of tumor metastases in the liver and spleen.
给DBA/2小鼠注射高度纯化的干扰素可抑制皮下植入的对干扰素敏感或耐药的Friend红白血病细胞的生长。在肿瘤接种部位注射干扰素比腹腔注射更有效。对接受干扰素治疗的小鼠的肿瘤进行组织学检查发现,在没有明显宿主细胞浸润的情况下,肿瘤细胞出现广泛坏死区域。干扰素抑制已形成的皮下肿瘤的生长,并使一些小鼠的肿瘤完全消退。干扰素治疗还可抑制肿瘤在肝脏和脾脏中的转移。